止血和组织密封剂市场规模、份额和成长分析（按产品、材料、应用、最终用途和地区）- 产业预测 2025-2032

2023 年全球止血和组织密封剂市场规模价值 74.1 亿美元，预计将从 2024 年的 80.1 亿美元增长到 2032 年的 149.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.1%。

由于慢性病发病率上升和人口老化导致外科手术需求不断增加，全球止血和组织密封剂市场正在经历强劲增长。外科手术的激增需要有效的止血和密封产品来提高病人的安全。微创手术和先进手术技术的创新进一步增加了这种需求。製造商在研发上的持续投入，带来了功效更高、副作用更少的创新产品，赢得了医疗专业人士的信任。然而，市场面临严格的监管核准、高昂的医疗成本和报销问题等挑战，这些可能会阻碍新技术的采用。此外，竞争对手之间的激烈竞争导致价格压力，需要不断投资于研究和行销策略以维持市场地位。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 原料分析

止血和组织密封剂市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 局部止血剂
  • 动态的
  • 机械的
  • 流动性
• 黏合剂和组织密封胶
  • 合成组织组织密封胶
  • 天然组织密封胶
  • 防沾黏剂

止血和组织密封剂市场规模（按材料和复合年增长率） (2025-2032)

• 市场概况
• 明胶基局部止血剂
• 胶原蛋白局部外用止血剂
• 基于ORC的局部止血剂
• 多醣类局部止血剂

止血和组织密封剂市场规模（按应用和复合年增长率）（2025-2032）

• 市场概况
• 一般外科
• 神经外科
• 血管外科
• 心血管外科
• 其他的

止血和组织密封剂市场规模（按最终用途和复合年增长率划分）（2025-2032 年）

• 市场概况
• 医院
• 门诊手术中心
• 家庭护理设置
• 其他的

止血及组织密封剂市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Johnson & Johnson（United States）
• Baxter International Inc.（United States）
• Pfizer Inc.（United States）
• Integra LifeSciences Corporation（United States）
• Smith & Nephew plc（United Kingdom）
• B. Braun Melsungen AG（Germany）
• CryoLife, Inc.（United States）
• CSL Behring（Australia）
• Medtronic plc（Ireland）
• Zimmer Biomet Holdings, Inc.（United States）
• Ferrosan Medical Devices A/S（Denmark）
• Cohera Medical, Inc.（United States）
• Marine Polymer Technologies, Inc.（United States）
• Equimedical BV（Netherlands）
• Advanced Medical Solutions Group plc（United Kingdom）
• Cohesion Technologies, Inc.（United States）
• HyperBranch Medical Technology, Inc.（United States）
• Terumo Corporation（Japan）
• Mil Laboratories Pvt. Ltd.（India）

结论和建议

Global Hemostasis and Tissue Sealing Agents Market size was valued at USD 7.41 billion in 2023 and is poised to grow from USD 8.01 billion in 2024 to USD 14.94 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global hemostasis and tissue sealing agents market is witnessing robust growth, fueled by rising chronic disease incidences and an aging demographic, which increases the demand for surgical procedures. This surge in surgeries necessitates effective hemostatic and sealing products to enhance patient safety. Innovations in minimally invasive surgery and advanced surgical techniques further amplify this demand. Continuous R&D investments by manufacturers are resulting in innovative products with enhanced efficacy and minimal side effects, earning the trust of healthcare professionals. However, the market faces challenges, including stringent regulatory approvals, high healthcare costs, and reimbursement issues, which could hinder the adoption of new technologies. Additionally, intense competition among players leads to pricing pressures, requiring ongoing investments in research and marketing strategies to sustain market presence.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemostasis And Tissue Sealing Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemostasis And Tissue Sealing Agents Market Segments Analysis

Global Hemostasis and Tissue Sealing Agents Market is segmented by Product, Material, Application, End-use and region. Based on Product, the market is segmented into Topical Hemostats and Adhesive & Tissue Sealant. Based on Material, the market is segmented into Gelatin-based Topical Hemostats, Collagen-based Topical Hemostats, ORC-based Topical Hemostats and Polysaccharide-based Topical Hemostats. Based on Application, the market is segmented into General Surgery, Neurosurgery, Vascular Surgery, Cardiovascular Surgery and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Home Care Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hemostasis And Tissue Sealing Agents Market

The increasing inclination towards minimally invasive surgical methods has significantly heightened the demand for specialized hemostasis and tissue sealing agents utilized in laparoscopic, endoscopic, and robotic-assisted procedures. These agents are crucial in achieving effective hemostasis and securing tissue closure during surgeries that prioritize reduced invasiveness. Their ability to enhance surgical outcomes and minimize complications has made them essential in contemporary surgical practices. As the medical field continues to emphasize patient comfort and faster recovery times, the global market for these innovative hemostatic and sealing agents is expected to grow, reflecting the evolving landscape of surgical techniques and patient care.

Restraints in the Global Hemostasis And Tissue Sealing Agents Market

The Global Hemostasis and Tissue Sealing Agents market faces notable constraints stemming from the lengthy and expensive approval process associated with new products. Stringent regulatory standards necessitate extensive testing and documentation, which can significantly impede the introduction of innovative agents. As a result, the development cycle is prolonged, leading to delays in the commercialization of new offerings. This not only restricts market growth but also limits the availability of advanced treatments for patients, ultimately affecting the competitive landscape in this vital industry. Consequently, manufacturers may encounter challenges in bringing their products to market efficiently.

Market Trends of the Global Hemostasis And Tissue Sealing Agents Market

The Global Hemostasis and Tissue Sealing Agents market is experiencing a robust trend fueled by the rising preference for minimally invasive surgical procedures. This shift is largely driven by the benefits these techniques offer, including reduced incision sizes, minimized scarring, and expedited recovery times for patients. Consequently, there is an increasing demand for specialized hemostasis and tissue sealing agents that ensure optimal wound closure and effective tissue adhesion during these surgeries. As healthcare providers continue to adopt advanced surgical methodologies, the market for these agents is expected to expand significantly, presenting lucrative opportunities for manufacturers and suppliers in the region.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Raw Material Analysis

Global Hemostasis and Tissue Sealing Agents Market Size by Product & CAGR (2025-2032)

• Market Overview
• Topical Hemostats
  • Active
  • Mechanical
  • Flowable
• Adhesive & Tissue Sealant
  • Synthetic Tissue Sealant
  • Natural Tissue Sealant
  • Adhesion Barrier Products

Global Hemostasis and Tissue Sealing Agents Market Size by Material & CAGR (2025-2032)

• Market Overview
• Gelatin-based Topical Hemostats
• Collagen-based Topical Hemostats
• ORC-based Topical Hemostats
• Polysaccharide-based Topical Hemostats

Global Hemostasis and Tissue Sealing Agents Market Size by Application & CAGR (2025-2032)

• Market Overview
• General Surgery
• Neurosurgery
• Vascular Surgery
• Cardiovascular Surgery
• Others

Global Hemostasis and Tissue Sealing Agents Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Home Care Settings
• Others

Global Hemostasis and Tissue Sealing Agents Market Size & CAGR (2025-2032)

• North America (Product, Material, Application, End-use)
  • US
  • Canada
• Europe (Product, Material, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Behring (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferrosan Medical Devices A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marine Polymer Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Equimedical B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Medical Solutions Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohesion Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HyperBranch Medical Technology, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mil Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations